Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05395741
Title Regorafenib in Patients With Refractory Primary Bone Tumors (Regbone)
Acronym Regbone
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Institute of Mother and Child, Warsaw, Poland
Indications
Therapies
Age Groups: child | adult
Covered Countries POL


No variant requirements are available.